Colhoun, H., Betteridge, D., Durrington, P., Hitman, G., Neil, A., Livingstone, S., . . . Fuller, J. (2011). Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: An analysis from the CARDS trial.
Chicago-viite (17. p.)Colhoun, H., et al. Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients with Type 2 Diabetes: An Analysis from the CARDS Trial. 2011.
MLA-viite (9. p.)Colhoun, H., et al. Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients with Type 2 Diabetes: An Analysis from the CARDS Trial. 2011.